IndiaOne Finance - Company Dashboard

Governance Classic Home

Orchid Pharma LtdPharmaceuticalsINE191A01027Consolidated₹989.10+32.90 (+3.44%)Jun-26

Valuation

Market Cap₹5.02K Cr

TTM PE614.72x

Forward PE270.90x

PEG-10.27

Book Value₹253.91

P/B3.90x

TTM EPS₹1.61

Fwd EPS₹3.65

TTM Revenue₹942.57 Cr

TTM PAT₹8.67 Cr

TTM EBITDA₹40.96 Cr

TTM EBIT₹3.21 Cr

Last Qtr PAT₹3.22 Cr

Last Qtr EBITDA₹14.00 Cr

Last Qtr EBIT₹3.05 Cr

Profitability

ROE0.67%

ROCE2.29%

TTM NPM0.92%

TTM EBITDA %4.35%

Curr OPM1.05%

Last OPM9.71%

Curr NPM—

Last NPM—

Curr EPS₹0.54

Last EPS₹4.69

Balance sheet

Equity₹50.72 Cr

Reserve₹1.24K Cr

Total Debt₹358.48 Cr

D/E0.28x

Interest %69.25%

Curr Interest₹2.23 Cr

Price / range

Close₹989.70

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+3.30%

1W-1.47%

1M+2.17%

3M-2.05%

6M+83.68%

1Y+38.05%

2Y-29.58%

3Y+86.74%

5Y+18751.43%

Diwali+25.06%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	304.17+75.9%	237.61	207.27	193.52	172.93	811.33
Other Income	10.05	13.30	10.59	15.43	15.93	55.24
Total Income	314.22+66.4%	250.90	217.86	208.95	188.86	866.57
Interest	2.21	3.08	3.17	3.73	3.26	13.24
Expenditure	-302.28-77.1%	-220.84	-216.57	-206.72	-170.66	-814.79
PBDT	0	0	0	0	0	0
EBITDA	15+5.8%	29	2.84	-0.68	14.18	45.34
Depreciation	-10.90	-9.15	-8.97	-8.79	-8.65	-35.56
EBIT	4.10-25.9%	19.85	-6.13	-9.47	5.53	9.78
PBT	11.94-34.4%	30.60	-5.82	2.23	18.20	45.21
Tax	0	0	0	0	0	0
Equity	59.89	50.72	0	0	50.72	50.72
OPM	3.80	12.20	-2.81	1.15	9.64	5.22
Net Profit	11.94-34.4%	30.60	-5.82	2.23	18.20	45.21
NPM	3.80	12.20	-2.81	1.15	9.64	5.22
EPS	1.99-44.6%	6.03	-1.15	0.44	3.59	8.91

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	811.33-12.0%	921.93+12.5%	819.37+23.0%	665.90+19.6%	556.97+23.6%	450.70
Other Income	55.24	31.93	30.39	19.43	9	6.48
Total Income	866.57-9.2%	953.86+12.3%	849.76+24.0%	685.33+21.1%	565.98+23.8%	457.17
Expenditure	-814.79+3.8%	-847.37-11.8%	-758.23-13.3%	-669.29-8.2%	-618.75-11.9%	-553.04
Interest	-13.24	-14.54	-16.33	-32.23	-32.01	-51.34
PBDT	0	0	0	0	0	0
EBITDA	45.34-63.3%	123.54+11.6%	110.69+32.4%	83.63+46.1%	57.25-1.1%	57.90
Depreciation	-35.56	-34.44	-33.22	-54.79	-87.02	-108.90
EBIT	9.78-89.0%	89.10+15.0%	77.47+168.6%	28.84+196.9%	-29.77+41.6%	-51
PBT	45.21-57.5%	106.48+16.3%	91.52+65.6%	55.25+204.7%	-52.77+45.0%	-95.87
Tax	0	0	3.23	0	0	0
Equity	50.72	50.72	0	0	0	0
OPM (%)	5.22	11.16	11.00	8.00	-9.00	-21.00
Net Profit	45.21-57.5%	106.48+12.4%	94.75+74.8%	54.19+1226.6%	-4.81+95.9%	-117.15
NPM (%)	5.22	11.16	11.00	8.00	-1.00	-26.00
EPS (Rs)	8.91-57.6%	20.99+7.1%	19.59+47.5%	13.28+1225.4%	-1.18+95.9%	-28.70
CEPS	8.91	20.99	19.59	13.28	-1.18	-28.70

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	304.17+75.9%	237.61	207.27	193.52	172.93	811.33
Other Income	1.83	7.34	5.61	10.77	11.45	35.17
Total Income	306+66.0%	244.95	212.88	204.30	184.38	846.50
Interest	2.23	3.09	3.18	3.73	3.26	13.26
Expenditure	-303.35-77.7%	-222.70	-217.91	-207.63	-170.67	-818.91
PBDT	0	0	0	0	0	0
EBITDA	14-1.2%	26.87	1.57	-1.48	14.17	41.13
Depreciation	-10.95	-8.87	-9.03	-8.90	-8.65	-35.45
EBIT	3.05-44.7%	18	-7.46	-10.38	5.52	5.68
PBT	2.65-80.7%	22.79	0	0	13.71	21.02
Tax	-0.07	0	0	0	0	0.19
Equity	59.89	50.72	0	0	50.72	50.72
OPM	0.87	9.30	0.00	0.00	7.44	2.48
Net Profit	3.22-78.4%	23.78	-12.61	-5.72	14.91	20.55
NPM	1.05	9.71	-5.93	-2.80	8.09	2.43
EPS	0.54-81.6%	4.69	-2.49	-1.13	2.94	4.05

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	811.33-12.0%	921.93+12.5%	819.37+23.0%	665.90+19.0%	559.56+24.3%	450.06
Other Income	35.17	27.47	30.86	19.43	9	15.23
Total Income	846.50-10.8%	949.40+11.7%	850.23+24.1%	685.33+20.5%	568.56+22.2%	465.29
Expenditure	-818.91+4.1%	-853.84-12.6%	-758.29-13.3%	-669.29-6.4%	-628.98-12.2%	-560.54
Interest	-13.26	-14.54	-16.36	-32.23	-32.01	-51.34
PBDT	0	0	0	0	0	0
EBITDA	41.13-64.9%	117.18+5.9%	110.68+32.3%	83.63+68.5%	49.62-0.3%	49.78
Depreciation	-35.45	-34.55	-33.24	-54.79	-87.03	-108.92
EBIT	5.68-93.1%	82.63+6.7%	77.44+168.5%	28.84+177.1%	-37.41+36.7%	-59.14
PBT	21.02-78.0%	95.56+3.9%	91.95+66.4%	55.25+191.4%	-60.42+36.6%	-95.25
Tax	0.19	0.19	3.12	0	0	0
Equity	50.72	50.72	0	0	0	0
OPM (%)	2.48	10.07	10.81	8.06	-10.63	-20.47
Net Profit	20.55-79.4%	99.66+8.1%	92.17+99.0%	46.32+2475.4%	-1.95+98.3%	-116.53
NPM (%)	2.43	10.50	10.84	6.76	-0.34	-25.04
EPS (Rs)	4.05-79.4%	19.65+3.1%	19.06+67.9%	11.35+2464.6%	-0.48+98.3%	-28.55
CEPS	4.05	19.65	19.06	11.35	-0.48	-28.55

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2012	Final Dividend	3	13 Sep 2012
2011	Final Dividend	3	19 Jul 2011
2010	Final Dividend	10	12 Jul 2010
2009	Final Dividend	1	17 Sep 2009
2008	Final Dividend	3	18 Sep 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split